MedPath

ocalized epilepsy and neural networks.

Conditions
EpilepsyLesionBrain tumorLow grade gliomaMesiotemporal sclerosisMTS
Registration Number
NL-OMON21379
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Inclusion criteria for pharmacoresistant epilepsy patients are:

1. Adult ( 18 years);

Exclusion Criteria

Exclusion criteria are:

1. Psychiatric disease or symptoms;

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main study parameters are a ECoG and MEG-based measures, assessing functional connectivity (SL and PLI) and neuronal brain networks (cluster coefficient and path length), seizure frequency and epilepsy burden.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath